Technology
Health
Pharmaceutical

Oasmia Pharmaceutical

$3.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (2.78%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell OASM and other stocks, options, ETFs, and crypto commission-free!

About

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Read More The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Employees
58
Headquarters
Uppsala, Uppsala
Founded
1988
Market Cap
224.29M
Price-Earnings Ratio
Dividend Yield
Average Volume
31.58K
High Today
$3.06
Low Today
$2.84
Open Price
$2.91
Volume
1.10K
52 Week High
$5.70
52 Week Low
$1.20

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Research And Development
2015 IPO
Europe (Non-UK)
Europe

Earnings

-$0.07
-$0.05
-$0.04
-$0.02
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.